LB Pharmaceuticals
0 followers
LBRX
Performance
About LB Pharmaceuticals
LB Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric diseases, including schizophrenia and bipolar depression. The company is building a pipeline around lead candidate LB-102, a benzamide antipsychotic with potential to be the first of its class approved in the United States. Headquartered in the United States, LB Pharmaceuticals emphasizes targeted therapies for neuropsychiatric conditions and advances through clinical development and publications to support its scientific rationale.
Recent News
Recent Deals
No recent deals for this company.